JPWO2022191313A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022191313A5
JPWO2022191313A5 JP2023505652A JP2023505652A JPWO2022191313A5 JP WO2022191313 A5 JPWO2022191313 A5 JP WO2022191313A5 JP 2023505652 A JP2023505652 A JP 2023505652A JP 2023505652 A JP2023505652 A JP 2023505652A JP WO2022191313 A5 JPWO2022191313 A5 JP WO2022191313A5
Authority
JP
Japan
Prior art keywords
formula
compound represented
following formula
compound
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023505652A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022191313A1 (https=
JP7721635B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/010851 external-priority patent/WO2022191313A1/ja
Publication of JPWO2022191313A1 publication Critical patent/JPWO2022191313A1/ja
Publication of JPWO2022191313A5 publication Critical patent/JPWO2022191313A5/ja
Priority to JP2025126121A priority Critical patent/JP2025160360A/ja
Application granted granted Critical
Publication of JP7721635B2 publication Critical patent/JP7721635B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023505652A 2021-03-12 2022-03-11 糖鎖及び糖鎖を含む医薬品の製造方法 Active JP7721635B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025126121A JP2025160360A (ja) 2021-03-12 2025-07-29 糖鎖及び糖鎖を含む医薬品の製造方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021040164 2021-03-12
JP2021040164 2021-03-12
PCT/JP2022/010851 WO2022191313A1 (ja) 2021-03-12 2022-03-11 糖鎖及び糖鎖を含む医薬品の製造方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025126121A Division JP2025160360A (ja) 2021-03-12 2025-07-29 糖鎖及び糖鎖を含む医薬品の製造方法

Publications (3)

Publication Number Publication Date
JPWO2022191313A1 JPWO2022191313A1 (https=) 2022-09-15
JPWO2022191313A5 true JPWO2022191313A5 (https=) 2025-03-04
JP7721635B2 JP7721635B2 (ja) 2025-08-12

Family

ID=83228168

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023505652A Active JP7721635B2 (ja) 2021-03-12 2022-03-11 糖鎖及び糖鎖を含む医薬品の製造方法
JP2025126121A Pending JP2025160360A (ja) 2021-03-12 2025-07-29 糖鎖及び糖鎖を含む医薬品の製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025126121A Pending JP2025160360A (ja) 2021-03-12 2025-07-29 糖鎖及び糖鎖を含む医薬品の製造方法

Country Status (9)

Country Link
US (1) US20240279364A1 (https=)
EP (1) EP4306546A4 (https=)
JP (2) JP7721635B2 (https=)
KR (1) KR20230157983A (https=)
CN (2) CN121021596A (https=)
BR (1) BR112023017365A2 (https=)
CA (1) CA3212691A1 (https=)
IL (1) IL305816A (https=)
WO (1) WO2022191313A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250064682A (ko) * 2022-09-09 2025-05-09 다이이찌 산쿄 가부시키가이샤 신규 올리고당, 그 올리고당의 제조 중간체, 및 그것들의 제조 방법

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6051702A (ja) * 1983-08-30 1985-03-23 Rikagaku Kenkyusho 複合多糖およびその製造法
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
EP1400536A1 (en) 1991-06-14 2004-03-24 Genentech Inc. Method for making humanized antibodies
WO1996002255A1 (en) 1994-07-15 1996-02-01 Taiyo Kagaku Co., Ltd. Medicinal composition containing sialic acid derivative
US6235883B1 (en) 1997-05-05 2001-05-22 Abgenix, Inc. Human monoclonal antibodies to epidermal growth factor receptor
AU2002311919B8 (en) 2001-05-11 2007-03-22 Ludwig Institute For Cancer Research Ltd Specific binding proteins and uses thereof
WO2004008099A2 (en) 2002-07-15 2004-01-22 Genentech, Inc. METHODS FOR IDENTIFYING TUMORS THAT ARE RESPONSIVE TO TREATMENT WITH ANTI-ErbB2 ANTIBODIES
JP5356648B2 (ja) 2003-02-20 2013-12-04 シアトル ジェネティックス, インコーポレイテッド 抗cd70抗体−医薬結合体、ならびに癌および免疫障害の処置のためのそれらの使用
NZ566395A (en) 2005-09-26 2012-03-30 Medarex Inc Human monoclonal antibodies to CD70
JP2009155353A (ja) * 2006-03-30 2009-07-16 Yokohama City Univ 糖鎖化合物の製造方法
BRPI0816094A2 (pt) 2007-08-30 2015-03-03 Daiichi Sankyo Co Ltd Anticorpo, polipeptídeo, hibridoma, composição farmacêutica, método para inibir o desenvolvimento de tumor em um mamífero, polinucleotídeo, célula hospedeira, e, método para produzir um anticorpo.
US8809496B2 (en) 2009-09-03 2014-08-19 The Noguchi Institute Production method of 11-sugar sialylglycopeptide
US10851174B2 (en) * 2011-03-03 2020-12-01 University Of Maryland, Baltimore Core fucosylated glycopeptides and glycoproteins: chemoenzymatic synthesis and uses thereof
WO2012135049A1 (en) * 2011-03-25 2012-10-04 University Of Georgia Research Foundation, Inc. Compounds and methods for chemical and chemo-enzymatic synthesis of complex glycans
ES2773710T3 (es) 2012-10-11 2020-07-14 Daiichi Sankyo Co Ltd Enlazadores para conjugados de anticuerpo - fármaco
TW201442721A (zh) * 2013-01-23 2014-11-16 Daiichi Sankyo Co Ltd 糖鏈修飾心房利尿鈉肽
TW201534613A (zh) 2013-06-28 2015-09-16 Daiichi Sankyo Co Ltd 寡糖胜肽之純化方法
WO2015080603A1 (en) * 2013-11-28 2015-06-04 Antony John Fairbanks Glycoproteins
AU2014371934B2 (en) 2013-12-25 2020-01-23 Daiichi Sankyo Company, Limited Anti-TROP2 antibody-drug conjugate
US11559581B2 (en) 2015-01-09 2023-01-24 Oxford University Innovation Limited Antibody conjugates and methods of making the antibody conjugates
WO2017110984A1 (ja) 2015-12-25 2017-06-29 第一三共株式会社 限外ろ過膜を用いたオリゴ糖ペプチドの精製法
WO2018003983A1 (ja) 2016-07-01 2018-01-04 第一三共株式会社 hANP-Fc含有分子コンジュゲート
JP6342968B2 (ja) * 2016-07-25 2018-06-13 株式会社伏見製薬所 糖誘導体の製造方法及び新規糖誘導体
TW202532104A (zh) 2017-05-15 2025-08-16 日商第一三共股份有限公司 抗體-藥物結合物及其用途
NZ762505A (en) 2017-09-29 2026-03-27 Daiichi Sankyo Co Ltd Antibody-pyrrolobenzodiazepine derivative conjugate
EP3848054B1 (en) 2018-09-06 2025-01-29 Daiichi Sankyo Company, Limited Antibody-drug conjugates of cyclic dinucleotide derivatives

Similar Documents

Publication Publication Date Title
HU226771B1 (en) 2-sulfonyloxy-2-(2-chlorophenyl)-acetic acid methyl ester derivatives, process for their preparation and process for the praparation of clopidogrel using the same
JP2008511601A5 (https=)
CA2828389A1 (fr) Procede de synthese de derives de cetobenzofurane
JP2012149045A5 (ja) ベンゾ[b]ナフト[1,2−d]フラン化合物
KR0149508B1 (ko) 3-아릴옥사졸리디논 유도체, 그의 제조 방법 및 그의 치료 용도
JP5297655B2 (ja) 新規な含フッ素ポリマー
JPWO2022191313A5 (https=)
Ko et al. p-Nitrobenzoate esters of epoxy alcohols: Convenient synthons for water-soluble epoxy alcohols
JP2025501618A5 (https=)
US7355064B2 (en) Method for preparing 15-keto-prostaglandin E derivative
JP5453834B2 (ja) エステル化合物及びその製造方法
BRPI0620737A2 (pt) intermediário de epóxido na sìntese do tamiflu
CN101796037A (zh) 制备噁唑烷-氨基二醇和噁唑烷酮-氨基二醇及相关中间体的方法
EP0258160A2 (fr) Dérivés de 2,3 dihydrofuranne leur procédé de préparation, leur utilisation comme intermédiaire pour la préparation de tétrahydrofuranne
CA2465697A1 (en) Process for the preparation of (s)-naproxen 4-nitrooxybutyl ester
US5068345A (en) Oxazolidinone aldol adduct
US10508072B2 (en) Method for producing acid halide solution, mixed solution, and method for producing monoester compound
JPH04330070A (ja) ラブダン類およびその製造方法
JP2656417B2 (ja) 重合性フェノ−ル誘導体
JP4523324B2 (ja) ペルフルオロアルキル基を有するアルコール誘導体の製造方法
JP5026040B2 (ja) 新規な含フッ素スピロ環状アセタール化合物およびその製造方法
BRPI0616188A2 (pt) mÉtodos para preparar um composto, e para preparar (-)-halofenato, composto, e, composiÇço
JP2022528876A5 (https=)
PT89054B (pt) Processo para a preparacao de acido n-(bifenilmetil)-3-hidroxiglutaramico e seus derivados como agentes hipocolesterolemicos
JP6488638B2 (ja) α−フルオロアルデヒド類等価体の製造方法